SCHEMBL7233164

SCHEMBL7233164

Cc1ccc(N2CCN(c3ncccc3C(=O)NC(CO)Cc3ccccc3)CC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 5/20 0.62
CTSS P25774 2/20 0.62
TSHR P16473 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CHIA Q9BZP6 1/20 0.45
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ROCK2 O75116 3/20 0.43
ROCK1 Q13464 3/20 0.43
RPS6KA5 O75582 2/20 0.43
RPS6KA4 O75676 2/20 0.43
PRKACA P17612 2/20 0.43
MAPK1 P28482 2/20 0.43
GSK3B P49841 2/20 0.43
PRKX P51817 2/20 0.43
PRKG1 Q13976 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7243622 0.93 CAPN1 (0.70) CAPN1CTSSTSHRHSD17B10CHIA
SCHEMBL7241983 0.90 CAPN1 (0.64) CAPN1CTSSTSHRHSD17B10CHIA
SCHEMBL7232925 0.90 CAPN1 (0.59) CAPN1CTSSTSHRHSD17B10CHIA
SCHEMBL7241202 0.88 CHIA (0.59) CAPN1CTSSTSHRHSD17B10CHIA
SCHEMBL7239751 0.87 CAPN1 (0.59) CAPN1CTSSTSHRHSD17B10CHIA
SCHEMBL7235665 0.86 CAPN1 (0.55) CAPN1CTSSTSHRHSD17B10CHIA
SCHEMBL7243741 0.86 CAPN1 (0.61) CAPN1CTSSTSHRHSD17B10CHIA
SCHEMBL7242740 0.85 CAPN1 (0.57) CAPN1CTSSTSHRHSD17B10CHIA
SCHEMBL7243109 0.84 CAPN1 (0.56) CAPN1CTSSTSHRHSD17B10CHIA
SCHEMBL7233171 0.83 CAPN1 (0.57) CAPN1CTSSTSHRHSD17B10CHIA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562827-B1 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages ABBOTT LABORATORIES 2003-05-13 US disclosed